Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Reviews on Recent Clinical Trials|January 20, 2009
Treatment of colorectal liver metastases: a reviewM Van den Eynde, A HendliszClinical Colorectal Cancer|February 7, 2012
Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?E Seront, M Van den EyndeActa Clinica Belgica|April 14, 2011
Epidermal growth factor receptor targeted therapies for solid tumoursM Van den Eynde, J F Baurain, F Mazzeo, et al.Acta Gastro-Enterologica Belgica|October 24, 2018
The role of the pathologist and clinical implications in colorectal liver metastasisP Baldin, M Van den Eynde, C Hubert, et al.Head & Neck|June 20, 2012
Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: case report and review of the literatureI Sinapi, B Navez, M Hamoir, et al.Acta Gastro-Enterologica Belgica|March 22, 2018
Single-incision laparoscopic surgery for locally advanced colorectal cancer : feasibility, short-term and oncologic outcomesF Famiglietti, D Leonard, R Bachmann, et al.Psychopharmacology|February 1, 1994
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the ratL E van Beijsterveldt, R J Geerts, J E Leysen, et al.Acta Gastro-Enterologica Belgica|February 17, 2025
Selective internal radiation therapy for neuroendocrine liver metastases: efficacy, safety and prognostic factors. A retrospective single institution studyD Briol, A Ceratti, R Lhommel, et al.Acta Gastro-Enterologica Belgica|December 25, 2022
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: a 13 years-retrospective monocentric studyM Livin, D Leonard, R Bachmann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trialA Demols, I Borbath, M Van den Eynde, et al.Pageof 2